Atlas Trials

Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster

Clinical trial NCT07672626 · COMPLETED

Trial details

NCT number
NCT07672626
Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Vaccine
Start date
2022-07-19
Primary completion
2024-08-26
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.